Preview

Lorex Pharmaceuticals

Powerful Essays
Open Document
Open Document
1262 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Lorex Pharmaceuticals
Cougar Consulting
Memo
To: Carter Blakely
From: Charles Johnson of Cougar Consulting
Date: 3/15/2011
-------------------------------------------------
Re: Fill Rate for 10 ounce bottles of Linatol

Introduction
Lorex Pharmaceuticals recently gained FDA approval to market and sell a new product called Linatol. This memo will address the need to select a target amount to which each 10-ounce bottle of Linatol will be filled. The analysis of several target fill rates was conducted to determine the one that maximizes the contribution per case, therefore generating the maximum revenue for Lorex Pharmaceuticals. This ideal fill rate will allow more bottles to be sold at the full retail price of $186 and limit the under filled bottles that must be sold at a discount of $148.80.
Target Fill Rate Analysis
The current challenge presented in this case concerns striking a balance between maximizing revenue and controlling costs. Currently, the only fill rate that had been examined was 10.2 ounces. This target fill rate was chosen arbitrarily during the filling line test and no data existed that would make it economically justifiable. By working with varying target fill rates, calculating the proportion of bottles that would be filled correctly, then subtracting the costs from the revenue, the performance measure of contribution per case becomes very apparent. See contribution per case calculation in Exhibit “A”.
Based on data from the filling line test, calculations were conducted on target fill rates from 10.0 ounces to 10.5 ounces. Calculations are in Exhibit “B”. In order to accurately measure performance the first step was to determine which variables or costs would be relevant. Packaging cost per case, active ingredient cost per case, and rework cost per case were evaluated based on the effect they would have on the decision variable, which in this case is the target fill rate. Packaging cost per case became the only cost that was not calculated

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Q2 the industry standard was to charge 10 times the cost of production, which would put it at $400, given that the company is spending less on R&D, they could afford to lower the price. Company chose to price it at $410/vial…

    • 533 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Nate's Notes

    • 419 Words
    • 2 Pages

    John A. Quelch and Heather Beckham (2010), “Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug,” Harvard Business Case #: 4183, Harvard Business Publishing.…

    • 419 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    The full text of this report is available on the International Trade Administration’s Internet site at www.ita.doc.gov/drugpricingstudy. It is also available for purchase as a paper, microfiche, or electronic reprint from the National Technical Information Service, 5285 Port Royal Road, Springfield, VA 22161; www.ntis.gov.…

    • 47677 Words
    • 191 Pages
    Good Essays
  • Good Essays

    The manufacturing strategy team are reviewing the production of three key products which are manufactured in a factory in Northern France. They are going to re-formulate the manufacturing strategy they use to produce these products. As they are now short of capacity and do not have the resources available for further investment, his will include a review of which products they will continue to manufacture themselves and which they will outsource to China, and also which parts of the key processes of Active Ingredient (AI) Production, Formulation and Fill and Pack, that they will continue to do, and again which stages they will outsource to a 3rd party toller. They will also formulate the remaining elements of the…

    • 4513 Words
    • 19 Pages
    Good Essays
  • Best Essays

    Cited: Angell, Marcia. "Excess in the Pharmaceutical Industry." CMAJ : Canadian Medical Association journal = journal de l 'Association medicale canadienne 171.12 (2004): 1451-3. Web.…

    • 4286 Words
    • 18 Pages
    Best Essays
  • Better Essays

    Clark, T. (2003) Drinks market: UK, 2003. [WWW] Mintel Group Ltd. Available from: http://www.mintel.com/drinksmarket [Accessed 18/08/12]…

    • 1163 Words
    • 5 Pages
    Better Essays
  • Satisfactory Essays

    Misablaci Pharmaceutical

    • 408 Words
    • 2 Pages

    Misablaci Pharmaceutical can perform as a centralized or a decentralized organization. Many factors will determine whether Misablaci Pharmaceutical will employ centralized or decentralized operations. Since Misablaci Pharmaceutical is a large organization extending out globally both centralized and decentralized can be utilize. The company will perform in the centralized mode more effectively in the global operations. In centralization limited authority is given. This will be effective due to the partnership with Glasko Smith Kline. Employees working in the Japan company will receive all guidance and directions from upper management. The United States operations will be more effective in the decentralized…

    • 408 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Teva Pharmaceutical

    • 1493 Words
    • 6 Pages

    chance to Generic companies to have a 180 day exclusivity period if the generic company can…

    • 1493 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Dupont Pharmaceuticals

    • 1941 Words
    • 8 Pages

    After the two companies merged in 1989, they continued selling major medications such as Taxol for cancer, Pravachol and Monopril for cardiovascular disorders, antibiotics such as Cefzil, antidiabetics such as Glucophage, and the anti-clotting medication, Plavix. To continue to focus on pharmaceuticals, in the early years of 2000-2002, the company divested many of their non-pharmaceutical divisions, such as Clairol and the Mead-Johnson Nutritional division, and purchased DuPont Pharmaceuticals as well as an almost 20% share of ImClone Systems, which was getting ready to release a new anti-cancer drug, Erbitux (SEC eyes Bristol-Myers, 2002).…

    • 1941 Words
    • 8 Pages
    Good Essays
  • Good Essays

    Aspirin Case Summary

    • 463 Words
    • 2 Pages

    If Datril adopts the low-priced alternative, considering the $6 million expenditure on advertisement, it would need to sell 13 million bottles (approximately 3% of the sales quantity of aspirin) in order to break-even, an achievable target. (Exhibit 2)…

    • 463 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Lorex Pharmaceuticals

    • 380 Words
    • 2 Pages

    We can revise the filling target from 10.2 to reduce the no of under filled bottles without compromising on the gross margins. Various filling targets have been worked out on the next page…

    • 380 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Pepcid Case Study

    • 3127 Words
    • 13 Pages

    As self-medication is more widely adopted and healthcare payers seek to contain costs, the OTC market seems set for significant future growth. Most pharmaceutical companies anticipated rapid growth in the over-the-counter market as consumers increasingly sought to diagnose and self-medicate their common ailments. Many pharmaceutical companies are looking towards the OTC market for revenue protection and lifecycle extension for their major products. Although certain sectors of the OTC market are maturing, growth opportunities do exist in emerging markets and the leading antacids such as Mylanta, Maalox and Tums, those products ' market share dominance will be challenged.…

    • 3127 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    The research project chosen was the comparison of the 12 ounce cans of Pepsi and Coke. The research team of five, individually purchased and tested 3 cans each of Pepsi and Coke. Enclosed below will be the procedure which was followed to obtain the data. The methodology used to measure the liquid was changed to accommodate the way that the tools recorded the measurements. The implications of the changes will be discussed to show that the integrity of the process was maintained.…

    • 841 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Buying Forest Labs` Stocks

    • 3549 Words
    • 15 Pages

    Forest Labs is a pharmaceutical company that develops, manufacture and sell branded forms of ethical drug products most of which require a physician's prescription. Most of the drags are marketed directly, to physicians with a mission that a CEO and President of Forest Labs Howard Solomon in his letter to shareholders defines as “to increase shareholder value by obtaining and successfully marketing more and more fine pharmaceutical products”. Forest`s product pipeline highly depends on the licensing and acquisition of new product opportunities, currently covering a wide range of therapeutic products, helping with cardiovascular disease, chronic obstructive pulmonary disease, major depressive disorder, diabetes, infectious disease, and pain management. Among products are: BYSTOLIC® (nebivolol), DALIRESP® (roflumilast), FETZIMA™ (levomilnacipran extended-release capsules), LINZESS® (linaclotide), NAMENDA® (memantine HCl), NAMENDA XR™ (memantine HCl), SAVELLA® (milnacipran HCl), TEFLARO® (ceftaroline fosamil) for injection, TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder), and VIIBRYD® (vilazodone HCl).…

    • 3549 Words
    • 15 Pages
    Powerful Essays
  • Better Essays

    Lorex Pharmeceuticals

    • 1310 Words
    • 6 Pages

    After reviewing your request, Cougar Consulting performed an analysis to assist Lorex Pharmaceuticals in determining a target fill rate for Linatol. The target fill that we selected is intended to maximize expected contribution during the manufacturing process and was based on information contained in a report given to Cougar Consulting. The analysis that we performed is described in further detail.…

    • 1310 Words
    • 6 Pages
    Better Essays